These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33659944)

  • 1. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.
    Gittings LM; Sattler R
    Fac Rev; 2020; 9():12. PubMed ID: 33659944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis.
    Li X; Bedlack R
    Expert Opin Emerg Drugs; 2024 Jun; 29(2):93-102. PubMed ID: 38516735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for gene replacement therapies in amyotrophic lateral sclerosis.
    Giovannelli I; Higginbottom A; Kirby J; Azzouz M; Shaw PJ
    Nat Rev Neurol; 2023 Jan; 19(1):39-52. PubMed ID: 36481799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis.
    Nguyen L
    Cells; 2024 May; 13(11):. PubMed ID: 38891021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.
    Cunha-Oliveira T; Montezinho L; Simões RF; Carvalho M; Ferreiro E; Silva FSG
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.
    Liu J; Wang F
    Front Immunol; 2017; 8():1005. PubMed ID: 28871262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials.
    Khalid SI; Ampie L; Kelly R; Ladha SS; Dardis C
    Front Neurol; 2017; 8():486. PubMed ID: 28993751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS).
    Limpert AS; Mattmann ME; Cosford ND
    Beilstein J Org Chem; 2013; 9():717-32. PubMed ID: 23766784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.
    Mead RJ; Shan N; Reiser HJ; Marshall F; Shaw PJ
    Nat Rev Drug Discov; 2023 Mar; 22(3):185-212. PubMed ID: 36543887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research advances in amyotrophic lateral sclerosis, 2009 to 2010.
    Traub R; Mitsumoto H; Rowland LP
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):67-77. PubMed ID: 21080240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis.
    Giagnorio E; Malacarne C; Mantegazza R; Bonanno S; Marcuzzo S
    J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34137441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy.
    Wang H; Guan L; Deng M
    Front Neurosci; 2023; 17():1170996. PubMed ID: 37250416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The past, present and future of stem cell clinical trials for ALS.
    Thomsen GM; Gowing G; Svendsen S; Svendsen CN
    Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current view and perspectives in amyotrophic lateral sclerosis.
    Mathis S; Couratier P; Julian A; Corcia P; Le Masson G
    Neural Regen Res; 2017 Feb; 12(2):181-184. PubMed ID: 28400790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
    Sattler R; Traynor BJ; Robertson J; Van Den Bosch L; Barmada SJ; Svendsen CN; Disney MD; Gendron TF; Wong PC; Turner MR; Boxer A; Babu S; Benatar M; Kurnellas M; Rohrer JD; Donnelly CJ; Bustos LM; Van Keuren-Jensen K; Dacks PA; Sabbagh MN;
    Neurol Ther; 2023 Dec; 12(6):1821-1843. PubMed ID: 37847372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities.
    Soares P; Silva C; Chavarria D; Silva FSG; Oliveira PJ; Borges F
    Ageing Res Rev; 2023 Jan; 83():101790. PubMed ID: 36402404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.
    Van Harten ACM; Phatnani H; Przedborski S
    Trends Neurosci; 2021 Aug; 44(8):658-668. PubMed ID: 34006386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Amyotrophic Lateral Sclerosis Gene Discovery: Reflecting on Classic Approaches and Leveraging Emerging Technologies.
    Smukowski SN; Maioli H; Latimer CS; Bird TD; Jayadev S; Valdmanis PN
    Neurol Genet; 2022 Jun; 8(3):e669. PubMed ID: 35620141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.
    De Marchi F; Munitic I; Amedei A; Berry JD; Feldman EL; Aronica E; Nardo G; Van Weehaeghe D; Niccolai E; Prtenjaca N; Sakowski SA; Bendotti C; Mazzini L
    Neurosci Biobehav Rev; 2021 Aug; 127():958-978. PubMed ID: 34153344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.